Genscript Biotech Corporation (GNNSF)
Market Open
10 Aug, 20:00
OTC PINK 
$
3. 08
+0.15
+5.1195%
$
3.77B Market Cap
- P/E Ratio
- Div Yield
2,700 Volume
0 Eps
$ 2.93
Previous Close Want to track GNNSF and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
GNNSF trading today higher at $3.08, an increase of 5.1195% from yesterday's close, completing a monthly increase of 92.5% or $1.48. Over the past 12 months, GNNSF stock gained 45.283%.
GNNSF is not paying dividends to its shareholders.
The last earnings report, released on Mar 15, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on HKEX (HKD).
GNNSF Chart
People also search for
Genscript Biotech Corporation (GNNSF) FAQ
What is the stock price today?
The current price is $3.08.
On which exchange is it traded?
Genscript Biotech Corporation is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is GNNSF.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 3.77B.
Has Genscript Biotech Corporation ever had a stock split?
No, there has never been a stock split.
Genscript Biotech Corporation Profile
| Biotechnology Industry | Healthcare Sector | Mr. Jiange Meng CEO | OTC PINK Exchange | KYG3825B1059 ISIN |
| DE Country | 5,769 Employees | - Last Dividend | - Last Split | - IPO Date |
Genscript Biotech Corporation, an investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally. It operates through three segments: Life Science Services and Products; Biologics Development Services; and Industrial Synthetic Biology Products. The Life Science Services and Products segment provides products and services in various categories, including gene synthesis, oligonucleotide synthesis, peptide synthesis, protein engineering, antibody development, and life-science equipment and consumables, such as molecular diagnostics tools and genome editing materials for biology studies, pharmaceutical and drug discovery, disease diagnostics and vaccine, agriculture, environmental studies, and the food industry. The Biologics Development Services segment which helps biopharmaceutical and biotech companies accelerate the development of therapeutic antibodies, and gene/cell therapy products with an integrated platform. The Industrial Synthetic Biology Products segment develops and produces industrial enzymes through non-pathogenic microbial strains constructed using genetic engineering. Genscript Biotech Corporation was founded in 2002 and is headquartered in Nanjing, the People's Republic of China.
Contact Information
Address: Jiangning Science Park, Nanjing, China, 211100
Phone: 86 25 5889 7288
Website: https://www.genscript.com
